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ABSTRACT
DNA cytosine modifications are key epigenetic regulators of cellular processes in mammalian cells,
with their misregulation leading to varied disease
states. In the human malaria parasite Plasmodium
falciparum, a unicellular eukaryotic pathogen, little is known about the predominant cytosine modifications, cytosine methylation (5mC) and hydroxymethylation (5hmC). Here, we report the first identification of a hydroxymethylcytosine-like (5hmC-like)
modification in P. falciparum asexual blood stages
using a suite of biochemical methods. In contrast
to mammalian cells, we report 5hmC-like levels in
the P. falciparum genome of 0.2–0.4%, which are
significantly higher than the methylated cytosine
(mC) levels of 0.01–0.05%. Immunoprecipitation of
hydroxymethylated DNA followed by next generation sequencing (hmeDIP-seq) revealed that 5hmClike modifications are enriched in gene bodies with
minimal dynamic changes during asexual development. Moreover, levels of the 5hmC-like base in gene
bodies positively correlated to transcript levels, with
more than 2000 genes stably marked with this modification throughout asexual development. Our work
highlights the existence of a new predominant cytosine DNA modification pathway in P. falciparum and

opens up exciting avenues for gene regulation research and the development of antimalarials.

INTRODUCTION
In eukaryotic cells, gene regulation at the epigenetic level
is integral to most, if not all, physiological processes. The
main epigenetic factors include nuclear architecture, noncoding RNAs, the dynamic deposition and removal of histone modifications, and DNA methylation (1). Of these,
DNA cytosine methylation is the most stable epigenetic
mark and can be inherited over tens to hundreds of replication cycles and generations (2,3). It occurs at position 5
of the pyrimidine ring of cytosine (5mC) mainly in a CpG
dinucleotide context––sequences that are located in CpG islands (occurring at 60% of all gene promoters), in repetitive sequences, or in CpG island shores (4)––and is catalysed by de novo C5-DNA methyltransferases or DNMTs
(5). Methylation of promoter CpG islands in a symmetric
manner results in transcriptional repression of the corresponding gene due to poor recognition by transcription factors, and the recruitment of proteins involved in chromatin
remodelling such as methyl DNA-binding proteins (MBPs),
which create a repressive chromatin environment (5). Moreover, deregulation of DNA methylation and establishment
of new DNA methylation patterns are associated with the
under- or over-expression of select genes, ultimately leading
to inflammation, cancer and other diseases (1,3).
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present during P. falciparum in vitro culture. We then used
a validated antibody-dependent immunoprecipitation approach to delineate genome-wide hydroxymethyl-cytosine
distribution at different stages of intra-erythrocytic development. Our work challenges the current view of DNA cytosine methylation in P. falciparum (28): we show that 5mC
is present at very low levels in the parasite genome (0.05%
from mass spectrometric analysis) and that a 5hmC signal
cannot be detected by mass spectrometry. Instead, a signal
more hydrophobic than 5hmC was consistently detected,
and we refer to this modification as ‘5hmC-like’ throughout
this report. We demonstrate that this modified form is the
predominant cytosine modification in P. falciparum (0.2–
0.4% from a variety of biochemical techniques) and that
its levels in gene bodies positively correlate with gene expression. We speculate that the high oxygen level in infected
erythrocytes may favor the deposition of unusual cytosine
modifications, some of which may be 5mC derivatives, over
5mC in asexual stages of the malaria parasites.
MATERIALS AND METHODS
In vitro culture of Plasmodium falciparum
Blood stages of the P. falciparum laboratory strain 3D7,
clone G7 and NF54varsporo were grown according to Trager
and Jensen (30) with a few changes. Briefly, a mixed
stage culture of P. falciparum was grown in white blood
cell (WBC)-free O+ human erythrocytes (prepared from
whole blood by treatment with leukocyte-specific filters)
at a hematocrit of 4% in Roswell Park Memorial Institute (RPMI) 1640 medium containing L-glutamine (Invitrogen) supplemented with 1% v/v Albumax II (Invitrogen)
and 200 M hypoxanthine (C.C.Pro). The cultures were
grown in a gas environment of 5% CO2 , 1% O2 and 94%
N2 to a parasitemia of 3–8% before harvesting for downstream analysis. For synchronization, knob-positive parasites were selected by gelatin flotation using Plasmion (Fresenius Kabi) (31) and after re-invasion, treated twice with
5% sorbitol (Sigma) (32) to obtain parasites that were synchronized within a window of approximately 4 h, as evaluated by Giemsa staining.
Genomic DNA and RNA isolation
Infected human erythrocyte cultures at different parasitemia and synchronized at the ring (8–12 h post-invasion
(hpi)), trophozoite (28–32 hpi) or schizont (40–44 hpi) parasite stages were harvested and free parasites obtained by
saponin lysis (33). Subsequently, the parasite pellet was split
into two portions: one for genomic DNA extraction, the
other for total RNA extraction. Genomic DNA was prepared using the DNeasy Blood and Tissue kit (Qiagen) or
the Nucleospin Tissue kit (Machery-Nagel) as per manufacturer’s instructions and treated with RNAse to removing any contaminating RNA molecules. Additionally, to remove heme and its derivatives from the genomic DNA, it
was purified using magnetic bead-based clean up with Ampure XP beads (Beackman Coulter) at 1:1 ratio, according
to manufacturer’s instructions. Total RNA was prepared using the miRNeasy mini kit (Qiagen), as per manufacturer’s
instructions, along with on-column DNase digestion. DNA
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In 2009, 5-hydroxymethylcytosine (5hmC), a demethylation intermediate in the active [5mC to C] conversion pathway, garnered interest as an important epigenetic regulator
(6,7). 5hmC is generated by the Fe2+ - and 2-oxoglutaratedependent oxidation of 5mC by ten-eleven translocation
(TET) dioxygenase enzymes, with depletion of TET proteins resulting in global reduction of 5hmC levels (7,8). Although 5hmC levels are significantly lower than 5mC levels in most cellular systems studied to date, the first clue
for its function comes from embyronic stem cells (ESCs)
and cells from the central nervous system (CNS), where
5hmC constitutes up to 0.7% of all modified cytosines
(6). In ESCs, 5hmC is enriched at gene bodies of actively
transcribed genes as well as within extended promoter regions of Polycomb-repressed developmental regulators (9),
whereas in differentiated neurons, its presence within gene
bodies positively correlates to transcript levels (10–12):
this indicates that 5hmC’s role in transcriptional regulation is cell type-, gene- and development stage-specific. Finally, misregulation of 5hmC is observed in neuronal disorders such as Alzheimer’s disease, Huntington’s disease,
schizophrenia, etc. and cancers such as melanoma, pancreatic, haematopoietic malignancies, etc. (3,12–15) Taken
together, 5hmC is now considered to be the sixth base in
eukaryotic DNA and not just an intermediate in the 5mC
demethylation pathway.
In the case of the lethal human malaria parasite, Plasmodium falciparum, epigenetic gene regulation, via specialized nuclear architecture, histone modifications, histone
variants and chromatin-associated non-coding RNAs governs stage-specific biology, as the parasite develops within
the human host and mosquito vector (16). For instance,
during P. falciparum asexual blood stage development in
humans, key processes such as clonally variant expression
of surface-exposed virulence factors and commitment to
transmission stages (gametocytes) are epigenetically regulated by all of the above mechanisms, and associated to
disease pathogenesis (16,17). Furthermore, small molecules
that specifically target P. falciparum histone methylation
and acetylation have been shown to interfere with parasite
growth and survival in vitro and in vivo (18–21). However,
to date, the contribution of well-established cytosine modifications to parasite gene regulation remains poorly understood: one of the main deterrents has been the AT-rich nature (∼80% A+T content) of the P. falciparum genome (22).
In fact, after decades of debate over the existence of 5mC in
P. falciparum (23–28), in 2013, Le Roch and colleagues identified 5mC in genomic DNA prepared from P. falciparum
asexual blood stages using mass spectrometry and bisulfite conversion followed by sequencing (BS-seq) (28). However, because BS-seq does not distinguish between 5mC and
5hmC (29), it still remains unclear as to what the levels of
cytosine methylation and hydroxymethylation are in P. falciparum, and if indeed they play a role in regulating parasite
gene expression.
To conclusively address this, we utilized a combination
of biochemical and cell biological techniques to evaluate
the presence of cytosine hydroxymethylation in the P. falciparum genome. We took particular care to work with parasite genomic DNA preparations devoid of contaminating
DNA from human white blood cells, which are normally
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and RNA concentrations were measured using the NanoDrop Spectrophotometer (Thermo Fisher Scientific) and
Qubit Colorimetric Assay (Thermo Fisher Scientific).
South-western blotting assays

ELISA-based 5hmC quantification in P. falciparum genomic
DNA
Quantification of 5hmC/5hmc-like levels in P. falciparum
genomic DNA was performed using the Global 5hmC
quantification kit (ActiveMotif) with a few modifications
to the manufacturer’s protocol. Briefly, a 50 ml solution
of genomic DNA (@ 50 ng/ml) was sonicated for 10 min
(20 s ON; 20 s OFF) using a pre-chilled Bioruptor (Diagenode). This solution was then diluted to 2 ng/ml in sample dilution buffer provided with the kit, heat denatured at
98◦ C for 10 min and stored on ice. Simultaneously, 5hmC
DNA standards (included in the kit and used to generate a
standard curve) as well as unmethylated and hydroxymethylated DNA (Methylated DNA standard kit, ActiveMotif),
included as negative and positive controls, respectively, were
heat denatured at 98◦ C for 10 min and stored on ice. Next,
assay wells were coated with a DNA binding solution and
incubated for 1 h at room temperature (RT). Once coating
was complete, 50 ml of genomic DNA samples, standards
or controls, was added to an assay well and incubated for 2
h at 37◦ C. The subsequent steps, i.e. washing of wells, incubation with primary and secondary antibody solutions and
developing of each reaction, were carried out as per manufacturer’s instructions. Finally, the OD of the colorimetric
reaction was measured at 450 nm within 5 min of development using a Synergy 2 Multi-Detection Microplate Reader
(Biotek). The percentage 5hmC/5hmC-like levels in each
sample were calculated after plotting a standard curve in
Microsoft Excel. Note that the primary antibody used was
a mouse anti-5hmC monoclonal antibody (ActiveMotif) at
1/1000 dilution and the secondary antibody used was antimouse-HRP antibody (GE Lifesciences) at 1/2000 dilution.

Immunofluorescence assays
Anti-5hmC and anti-5mC immunofluorescent staining was
performed as previously described (35) with a few modifications. Free P. falciparum parasites were obtained after saponin lysis (33), washed with phosphate-bufffered
saline (PBS), and fixed with 0.0075% Glutaraldehyde / 4%
Paraformaldehyde for 30 min at RT. Cells were then permeabilized with 0.1% Triton X-100 in PBS for 15 min at RT
and DNA denatured by adding 4N HCl for 20 min at RT.
HCl was washed away and 100 mM Tris pH 8.0 was added
for 10 min at RT for neutralization. Cells were then washed
with PBS + 0.05% Tween-20 (PBST) and free aldehydes
were quenched using 50 mM NH4 Cl in PBS before blocking with PBS + 3% Bovine Serum Albumin. After blocking,
primary anti-5hmC (Mouse monoclonal, Activemotif) or
anti-5mC antibodies (Mouse polyclonal, Eurogentek) were
added at 1/250 dilution for 1 h at RT. Anti-Histone3 (Rabbit; Abcam) primary antibodies were also added as a positive control to stain the nucleus. Cells were then washed
three times with PBST and the following secondary antibodies were added at 1:2000 dilution for 30 min at RT: Goat
anti-Mouse conjugated to Alexafluor-488 and Goat antiRabbit conjugated to Alexafluor-647. Finally, after washing
with PBS, 5 ml of cells were mounted in Vectashield fluorescent mounting medium and images were acquired using a
Deltavision Elite imaging system (GE Healthcare). Images
were processed using Fiji/ImageJ.
Preparation of cytoplasmic and nuclear extracts
Plasmodium falciparum cytoplasmic and nuclear extracts
were prepared from 3 ml of infected RBCs synchronized
at the R, T or S stages, harvested at a parasitemia of 6 to
8% as previously described (36). The only change was that
for nuclear fraction extraction, the extraction buffer was
changed to 20 mM HEPES pH 7.9, 600 mM NaCl and 1
mM DTT. The resulting cytoplasmic and nuclear fractions
were aliquoted, snap-frozen and stored at −80◦ C until further use. Protein concentration was measured using a Bradford assay and the Qubit Colorimetric Protein Assay.

ELISA-based 5mC quantification in P. falciparum genomic
DNA

TET activity assay using P. falciparum nuclear extracts

Quantification of 5mC levels in P. falciparum gDNA was
performed using the methylated DNA quantification kit

TET-like activity of P. falciparum nuclear extracts was measured using the TET hydroxylase activity quantification
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South-western blotting assays of P. falciparum genomic
DNA and DNA standards (Methylated DNA standard
kit from ActiveMotif) were performed as previously described (34), but without using a DNA-binding protein.
DNA prepared as described above from matched volumes of WBC-free uninfected blood served as a control.
Primary antibodies used include anti-5mC (rabbit monoclonal; Abnova), anti-5mC (mouse monoclonal; Eurogentec), anti-5hmC (mouse monoclonal; ActiveMotif) and
anti-5hmC (mouse monoclonal; Millipore) antibodies. No
cross-reactivity was observed between 5hmC and 5mC, 5fc,
5cac and 5C for the anti-5hmC antibodies (Source: Active motif). HRP-conjugated secondary antibodies include
anti-rabbit IgG and anti-mouse IgG from GE LifeSciences
that were compatible with ECL Western Blotting Detection
Reagents (Thermo Fisher Scientific).

(Abcam) according the manufacturer’s instructions. Briefly,
100 ng of DNA samples, positive and negative controls
(provided in the kit), were bound to assay wells for 90
min at 37◦ C. Wells were washed three times and primary anti-5mC antibody was added to all assay wells for
1 h at RT. Wells were then washed and secondary antibody was added to all assay wells for 30 min at RT. The
subsequent steps of fluorescence developpement were carried out according to manufacturer’s instrucations, and
RFU (Relative fluorescence units) was measured using a
Synergy 2 Multi-Detection Microplate Reader (Biotek) at
Excitation/Emission = 530/590nm. 5mC percentage in
each sample was calculated after plotting a standard curve
in Microsoft Excel.
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Bisulfite (BS) and oxidative bisulfite (oxBS) sequencing
Treatment of genomic DNA prepared from P. falciparum
asexual stage parasites with sodium bisulfite alone (BS)
or with an oxidizing agent followed by sodium bisulfite
(oxBS) was initially performed for pilot experiments using the TrueMethyl® Whole Genome Bisulfite Sequencing kit (Cambridge Epigenetix) according to manufacturer’s
instructions. Spike-in DNA controls to estimate bisulfite
conversion and oxidation efficiencies were provided with
the kit and added prior to the chemical treatments. The
treated DNA was further processed with the same kit to
generate DNA libraries that were compatible with Illumina
sequencing-by-synthesis. For the data presented in this report, BS-seq and oxBS-seq libraries were prepared using the
Ovation® Ultralow Methyl-Seq with TrueMethyl® oxBS
module kit (NuGen) according to manufacturer’s instructions; spike-in controls were obtained from Cambridge Epigenetix as above. All libraries were multiplexed and run on
an Illumina NextSeq 500 as a paired-end run of 150 nt. The
resulting fastq file was demultiplexed using bcl2fastq2 Conversion Software v2.17 (Illumina) and further analyzed as
described below.
Analysis of BS-seq and oxBS-seq data
Quality control of fastq files was performed using the
FastQC software (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/) after which Cutadapt v1.14 (37) was
used to cut adapter sequences and trim low quality bases
(Q < 20) from the 3 -end of reads. The resulting highquality reads were aligned to the P. falciparum 3D7 reference genome (http://genedb.org; v3, PlasmoDB v13.0) using Bismark v.0.14.5 (38). Duplicated reads were removed
from the raw alignments using SAMtools v0.1.19 (39) and
further filtered for quality (Q < 30). Properties of the BSand oxBS-seq datasets generated in this study and related
statistics are provided in Supplementary Table S1.
Spike-in analysis. We estimated the methylation conversion rate of the BS- and oxBS-seq libaries using the six
spike-in controls provided by the TrueMethyl kit. These
spike-in controls contain an expected set of methylated
(both 5mC and 5hmC) and unmethylated (truth set)
loci. The fastq reads were aligned to the spike-in control sequences using the cegx-bsExpress algorithm (https:
//bitbucket.org/cegx-bfx/cegx bsexpress docker), and the
number of true positives and false positives were calculated

at varying read depths based on the conversion summary
provided by cegx-bsExpress. For BS-seq libraries, sensitivity for 5mCs was defined as the proportion of 5mCs from
the truth set that were called as methylated by our pipeline
at a given depth cutoff. Similarly, sensitivity for 5hmCs was
defined as the proportion of 5hmCs from the truth set that
were called as methylated by our pipeline at a given depth
cutoff. False positive rate (FPR) was calculated as the proportion of unmethylated cytosines from the truth set that
were called as methylated by our pipeline at a given depth
cutoff. For oxBS-seq libraries, sensitivity of 5mCs was calculated as described above, and FPR was calculated as the
proportion of unmethylated cytosines and 5hmCs from the
truth set that were called as methylated by our pipeline
at a given depth cutoff. At depth ≥5× and % of methylated reads ≥10% (i.e. ≥1 read), we observed a sensitivity
of ≥96% and a FPR of ≥2.5% (Supplementary Table S2).
These cutoffs were used for all subsequent analyses.
Methylkit-based determination of 5hmC loci. Deduplicated and filtered alignments were used as inputs
to methylKit v0.9.2 (40) to estimate methylation percentages at CpG, CHG and CHH contexts. Loci with a
minimum read coverage of 5× with at least 1 methylationcontaining read were considered for down-stream analysis
based on our spike-in results. The resulting calls from the
BS-seq and oxBS-seq samples were compared to identify
5mC and 5hmC/5hmC-like loci. Specifically, loci that
were found to be methylated in both BS-seq and oxBS-seq
were classified as 5mCs whilst those that were methylated
in BS-seq and unmethylated in oxBS-seq were classified
as 5hmCs or 5hmC-like bases. Alternately, we processed
the de-duplicated alignments using Methpipe (41) and
identified between 34–70% of the 5hmC/5hmC-like loci
identified by Methylkit. We decided to use the Methylkit
lists for downstream analysis.
Data were visualized using the Integrative Genomics
Viewer (IGV) browser v.2.3.90 (42). For representation of
5hmC/5hmC-like genome-wide distribution, the coverage
of each mark was calculated as average reads per million
over bins of 2000 nt using bedtools v2.19.0 (43) and correlations between the genome-wide distributions were calculated using deeptools2 v3.1.1 (44).
hmeDIP-seq and RNA-seq library preparation and sequencing
Hydroxymethylated DNA Immunoprecipitation (hmeDIP)
was performed using the hmeDIP kit from ActiveMotif according to manufaturer’s instructions. The starting material
was genomic DNA from the Ring stage sheared using a prechilled Bioruptor (Diagenode) for 10 min, 30 s ON and 30
s OFF to a size of 200–400 bp. The immunoprecipitated
DNA was processed using the MicroPlex Library Preparation Kit v2 (Diagenode) with the KAPA Hifi polymerase for
library amplification. All libraries were multiplexed and run
on an Illumina NextSeq 500 as a paired-end run of 150 nt.
The resulting fastq file was demultiplexed using bcl2fastq2
Conversion Software v2.17.
For transcriptomic analysis, 4 g of total RNA from
Ring or Schizont stage parasites was poly(A)-enriched us-

Downloaded from https://academic.oup.com/nar/article-abstract/48/1/184/5644996 by Jackson Laboratory user on 08 January 2020

kit (fluorometric) from Abcam as per manufacturer’s directions. A total of 5 g of nuclear extracts was used
per reaction. As a positive control, human recombinant
TET1 protein (Abcam) was included in the assay. Extracts prepared as described above from matched volumes
of WBC-free uninfected blood served as an additional
control. The resulting fluorescence was measured at 530
nm excitation/590 nm emission using a Synergy 2 MultiDetection Microplate Reader. TET hydroxylase activity is
represented as nanograms of DNA converted per minute
per milligram of protein. This was calculated based on a
standard curve generated using Microsoft Excel.
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Analysis of hmeDIP-seq and RNA-seq data
Quality control of fastq files was performed using the
FastQC software (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/) and Cutadapt. High quality reads were
mapped to the P. falciparum 3D7 genome (http://genedb.
org; v3, PlasmoDB v13.0) using the Burrows-Wheeler
Alignment tool Bowtie 2 v.2.2.3 under default settings (45).
SAMTools was used to remove duplicates for all hmeDIPseq samples. Properties of the RNA-seq and hmeDIP-seq
datasets generated in this study and related statistics are
provided in Supplementary Table S1.
For hmeDIP-seq analysis, deduplicated bam files filtered
for quality (Q > 30) using SAMtools served as a starting point to identify enriched peaks in immunoprecipitated DNA relative to the genomic DNA input. First, correlation of the bam files of the different stages was calculated using bedtools and deepTools2. Second, enrichment peaks were identified using the MACS2 software
(46) after controlling for a false discovery rate (q-value)
of 1%. Correlation of the different MACS2 peak files
was determined using deepTools2 and bedGraphtobigwig
as previously described (https://github.com/taoliu/MACS/
wiki/Build-Signal-Track). Linear coverage plots were visualized using the IGV browser. Gene Ontology (GO) analysis was performed in PlasmoDB (https://plasmodb.org) and
reductionist analysis of GO terms performed using Revigo
(47).
For RNA-seq analysis, bam files were filtered down to
either the gene body (exons and introns) or exonic regions
alone using bedtools. The resulting alignments were used
as inputs to the featureCounts (48) from Subread v1.5.2 to
count the number of non-duplicate, uniquely aligned (mapping quality > 30) reads per gene. Custom R function was
used to calculate FPKM (Fragments Per Kilobase of transcript per Million mapped reads) per gene from the raw
counts.
Identification and quantification of 5hmdC and 5mdC in Plasmodium falciparum DNA by LC-MS/MS
Purified P. falciparum genomic DNA was hydrolyzed enzymatically as described (49–51) with a modified protocol. The digestion mix contained 10 mM Tris–HCl (pH
7.9), 1 mM MgCl2 , 5 U Benzonase (99% Purity Merck
71206), 50 M Desferroxamine (Sigma D9533), 0.1 g/l
Pentostatin (Sigma SML0508), 100 M Butylated hydroxytoluene (Sigma W218405), 0.5 g/l Tetrahydrouridine
(Calbiochem 584222), 5 U Bacterial Alkaline Phosphatase
(Thermo Fischer 18011015), 0.05 U Phosphodiesterase I

(Affymetrix P3243). Hypersil GOLD aQ column [100 ×
2.1 mm, 1.9 m (Thermo Scientific 25305)] was used to resolve the digested deoxyribonucleosides in a two-buffer eluent system which was composed as follows: buffer A = 0.1%
formic acid in water and buffer B = 0.1% formic acid in
acetonitrile). Synthetic hm5 dC and m5 dC were purchased
from Cayman Chemicals (Items 18 162 and 16 166, respectively). HPLC was performed at a flow rate of 300 l/m
at 25◦ C. The gradient of 0.1% formic acid in acetonitrile
was as follows: 0–12 min, held at 0%; 12–15.3 min, 0%1%; 15.3–18.7 min, 1%-6%; 18.7–20 min, held at 6%; 20–
24 min, 6%-100%; 24–27.3 min, held at 100%; 27.3–28 min,
100%-0%; 28–41 min, 0%. The HPLC column was directly
connected to an Agilent 6490 triple quadrupole mass spectrometer with ESI Jetstream ionization operated in positive
ion mode. The voltages and source gas parameters were as
follows: gas temperature: 200◦ C; gas flow: 15 l/min; nebulizer: 30 psi; sheath gas temperature: 300◦ C; sheath gas flow:
12 l/min; capillary voltage 1800 V and nozzle voltage, 0V.
The molecular transition ions were quantified in multiplereaction monitoring (MRM) mode.
Statistical analyses
For biochemical assays (5hmC quantification and TET activity assay), a minimum of three biological replicates were
analyzed. Statistical analysis was performed in Microsoft
Excel 2008. Results were plotted using Plotly (52).
For differences in mRNA expression between hydroxymethylated and unhydrooxymethylated gene sets, after a
preliminary analysis in Microsoft Excel 2008 to determine
sample variance, P-values were calculated using the nonparametric Mann–Whitney U-test. Box plots were generated using Plotly.
RESULTS
Identification of a 5hmC-like modification in the genome of
the malaria parasite P. falciparum
To examine the presence of unexplored cytosine modifications in P. falciparum, we denatured genomic DNA prepared from parasites of the 3D7-G7 strain (53) grown in
WBC-free blood, spotted them onto nylon membranes and
probed the membrane with either anti-5mC or anti-5hmC
antibodies from different sources (see ‘Materials and Methods’ section). Genomic DNA prepared from all three stages
(synchronized at the Ring (R; 8–14 h post-invasion (hpi)),
Trophozoite (T; 24–28 hpi) and Schizont (S; 38–42 hpi)),
reacted with the anti-5hmC antibodies, indicating the presence of a new DNA modification, 5hmC or 5hmC-like, in
the parasite genome: Figure 1A and Supplementary Figure
S1A show typical examples of our south-western blotting
results, with DNA preparations from uninfected WBC-free
blood showing zero reactivity to all antibodies tested (Supplementary Figure S1B). Additionally, we performed immunofluorescence assays on fixed 3D7-G7 parasites using
the primary antibodies from Figure 1A and observed that
the fluorescence signal was restricted to the nucleus, further supporting the existence of this novel DNA modification in vivo (Figure 1B). Finally, we used an ELISA-based
assay to quantify the levels of this new modification in P.
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ing the Dynabeads mRNA purification kit (Thermo Fisher
Scientific), and used for strand-specific RNA-seq library
preparation with the TruSeq Stranded mRNA LT Sample
Prep Kit (Illumina) according to manufacturer’s instructions. The only change was that library amplification was
performed using KAPA Hifi polymerase (KAPA Biosystems). All libraries were multiplexed and run on an Illumina NextSeq 500 as a paired-end run of 150 nt. The resulting fastq file was demultiplexed using bcl2fastq2 Conversion Software v2.17.
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falciparum genomic DNA extracted from two strains, 3D7G7 and NF54varsporo (54), and found that its levels varied between 0.19–0.38% during asexual development (Figure 1C).
Interestingly, the ELISA-based quantification yielded very
low numbers for 5mC levels in the P. falciparum genome, at
0.01–0.02%; this is in contrast to the report from Ponts et al.
(28) that identified substantially higher 5mC levels (0.47–
0.58%) in P. falciparum genomic DNA by mass spectrometry. The observed dominance of a 5hmC-like modification
over 5mC in a eukaryotic genome is unprecedented (55–57)
(Figure 1C and Supplementary Figure S1C) and indicates
that the parasite might have evolved to use the 5hmC-like
modification in a unique manner.
We also queried if TET proteins, the writers of 5hmC,
are expressed by P. falciparum asexual stage parasites. We
first measured TET hydroxylase activity in nuclear extracts
prepared from Ring and Schizont stages of P. falciparum using an ELISA-based colorimetric assay, with extracts from
uninfected WBC-free blood serving as a negative control,
and detected TET-like activity in all parasite samples, with
highest activity in Ring stage nuclear extracts, indicating
that a TET-like protein is indeed expressed by the parasite
(Supplementary Figure S2). However, the latest annotation
of the P. falciparum genome does not include a TET homologue or orthologue neither could we identify a TET-

like protein in P. falciparum using hidden markov model
(HMM)-based predictions. The identification of the gene(s)
coding for the observed enzymatic activity, however, is beyond the scope of this report. Nonetheless, our data, for the
first time, establish the presence of a 5hmC-like modification in the genome of a eukaryotic pathogen.
Hydroxymethylation is the predominant cytosine modification in P. falciparum asexual stages
Thereafter, to determine the genome-wide distribution of
the 5hmC-like modification at single nucleotide resolution,
we performed bisulfite sequencing (BS-seq) and oxidative
bisulfite sequencing (oxBS-seq) of genomic DNA derived
from two developmental stages, Ring (R; 8–14 hpi) and
Schizont (S; 38–42 hpi)––stages that have distinct transcriptomic profiles (58,59)––of two P. falciparum strains,
3D7-G7 and NF54varsporo , using the TrueMethyl technology
(60,61) (Figure 2A). Briefly, we treated genomic DNA supplemented with tailed spike-in controls with sodium bisulfite alone (Figure 2A; top), or sequentially with the oxidizing agent potassium perruthenate and sodium bisulfite (Figure 2A; bottom) to yield BS (5mC + 5hmC (or
5hmC-like)) and oxBS (5mC) samples, respectively. These
were then processed for multiplexed Illumina sequencing-
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Figure 1. A 5hmC-like modification is the predominant cytosine modification in the Plasmodium falciparum genome. (A) Southwestern blotting analysis
of genomic DNA prepared from Ring (R), Trophozoite (T) or Schizont (S) stage P. falciparum 3D7-G7 parasites using antibodies against 5mC (Abnova)
or 5hmC (Activemotif). Unmethylated, methylated or hydroxymethylated DNA standards (Activemotif) served as controls. The total amount of DNA
used is indicated in ng. (B) Immunostaining of Ring (R) or Schizont (S) stage P. falciparum 3D7-G7 parasites with anti-5hmC (top) or anti-5mC (bottom)
antibodies. Anti-histone H3 antibodies were used as a positive control for nuclear staining. BF = Brightfield. (C) ELISA-based quantification of 5hmC
(blue) or 5mC (gray) levels in genomic DNA prepared from Ring (R) or Schizont (S) stage parasites of the NF54varsporo and 3D7-G7 strains. The positive
controls were the methylated (5mC) and hydroxymethylated (5hmC) DNA standards used in part 1A. Data were calculated as a percentage and represent
the means of three independent experiments + standard errors of means (S.E.M.).
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by-synthesis and the resulting libraries sequenced using a
paired-end run of 150 nt. After performing quality control
analysis of fastq files (Supplementary Table S1), conversion
efficiency of the spike-in controls was measured for each
sample using cegx-BSexpress (Supplementary Figure S3A–
H), and sensitivity and FPR values estimated at varying sequencing depths (≥5, ≥10, ≥20 and ≥30) and methylation
proportion (i.e. % of reads supporting methylation at the

given sequencing depth) with a P-value cutoff of 0.05 (Supplementary Table S2). Based on this, we chose a sequencing
depth of ≥5 and a methylation proportion cutoff of 10% for
downstream analysis.
Next, the fastq files were aligned to the P. falciparum
genome (http://genedb.org; v3) using a bisulfite-aware algorithm, Bismark (38), and the numbers of methylated cytosines calculated for each sample (Supplementary Table
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Figure 2. BS- and oxBS-seq profiling confirms that a majority of modified cytosines in Plasmodium falciparum are 5hmC-like in nature. (A) Schematic
representation of the BS- and oxBS-seq methodology. Genomic DNA prepared from synchronized P. falciparum parasites was treated with sodium bisulfite
alone (BS-seq; top panel) or with an oxidizing agent prior to sodium bisulfite treatment (oxBS-seq; bottom panel). The resulting DNA was processed for
Next Generation Sequencing and a subtraction of oxBS-seq signals from BS-seq signals yielded 5hmC distribution at single nucleotide resolution. See
‘Materials and Methods’ section for additional details. (B) Measured 5hmC (blue) or 5mC (grey) levels (relative to total cytosines in the P. falciparum
genome, at 5 dpge and 10% methylation proportion and represented as a percentage) in Ring (R) or Schizont (S) stage BS- and oxBS-seq samples for the
NF54varsporo and 3D7-G7 strains. Data represent the means of three independent experiments + S.E.M. (C) Pearson correlation analysis of the 5hmC-like
profiles (calculated for bigwig files normalized over 500 nt bins) for the different BS- and oxBS-seq replicates for genomic DNA extracted from Ring (R) or
Schizont (S) stage parasites of the NF54varsporo and 3D7-G7 strains. The colour scale indicates the value of the Pearson Correlation Coefficient R from −1
to 1. (D) Overlap in the number of 5hmC-like loci identified in BS- and oxBS-seq replicates of the indicates samples of the NF54varsporo and 3D7-G7 strains.
(E) The percentage of 5hmC-like loci found in the CpG (black), CHG (yellow) or CHH (white) context was calculated for the indicated parasite strain and
growth stage: R = Ring and S = Schizont, from the BS- and oxBS-seq data. Data represent the means of three independent experiments + S.E.M.
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hmeDIP-seq reproducibly identifies the genome-wide distribution of 5hmC-like modifications in P. falciparum
Hydroxymethylated DNA immunoprecipitation (hmeDIP)
followed by next generation sequencing (-seq) is routinely
used to characterize the distribution of 5hmC (62–64). For
P. falciparum hmeDIP-seq, we isolated genomic DNA from
three biological replicates of the 3D7-G7 strain synchronized at the Ring (R; 6–10 hpi), Trophozoite (T; 24–28
hpi) and Schizont (S; 38–42 hpi) stages, sheared the DNA
to fragments that were 300–400 bp in size and immunoprecipitated 5hmC-enriched DNA using anti-5hmC antibodies (Figure 3A); rabbit IgG antibodies were used as
a negative control for immunoprecipitation (IP). The immunoprecipitated DNA was processed for multiplexed Illumina sequencing-by-synthesis and the resulting libraries sequenced using a paired-end run of 150 nt. After performing
quality control analysis of fastq files (Supplementary Table S1), the sequences were aligned against the P. falciparum
genome (https://genedb.org; v3) to yield BAM files.

Given that hmeDIP-seq has been standardized for
genomes with higher G+C content as compared to P. falciparum such as humans and mice, and given the poor performance of BS- and oXBS-seq for the P. falciparum genome
(Figure 2), we first evaluated the reproducibility of our
hmeDIP-seq experiments by measuring the Pearson correlation coefficient R values between the various BAM alignment files. As shown in Figure 3B, we observed a segregation of the hmeDIP-seq samples into a cluster that is distinct from the IgG control IPs and the Input DNA samples, which were also processed for Illumina sequencing-bysynthesis as described above. In fact, the control reactions
were better correlated to the Input DNA samples as compared to the hmeDIP-seq samples. Interestingly, the values
of R ranged from 0.8 to 1.0 between the Ring, Trophozoite
and Schizont stage hmeDIP-seq samples suggesting that the
5hmC-like profiles of the P. falciparum genome at different
growth stages might be similar.
Next, we used the peak-calling software ‘Model-based
analysis of ChIP-seq’ or MACS2 (46) to delineate hmeDIPenriched regions of the P. falciparum genome relative to
the corresponding Input DNA. A similar analysis was performed for the IgG control IPs. When we evaluated the
Pearson correlation coefficient R values between the various MACS2 fold enrichment (FE) profiles, we found that
the ‘hmeDIP versus Input’ FE profiles of various growth
stages clustered independently from the ‘control IP versus
Input’ FE profiles (Figure 3C). A similar separation was observed using a Principal Component Analysis (PCA) analysis, along the second principal component axis (Figure
3D). Of note, in the PCA analysis, the Trophozoite stage
‘hmeDIP versus Input’ FE profile segregated distinctly from
the Ring and Schizont stage FE profiles along the first principal component axis. Taken together, we conclude that
hmeDIP-seq performs reproducibly and robustly to study
the distribution of 5hmC-like marks in the P. falciparum
genome.

The 5hmC-like modification is predominantly found in gene
bodies and appears to be stably maintained during intraerythrocytic development
We calculated the number of MACS2-derived, hmeDIPenriched peaks in the Ring, Trophozoite and Schizont samples at a log2 (fold change) ≥ 1 and false discovery rate <
0.05 and identified 4148, 4603 and 4080 peaks, respectively
(Supplementary Table S8). Of these, 98–98.5% of the peaks
mapped to genic regions, described here as the region covering 1 kb upstream of START codon, gene body (introns
and exons) and 1 kb downstream of STOP codon (Figure
4A). The remaining 1–1.5% of the so-called intergenic peaks
mapped to chromosome ends, primarily to telomeric sequences (Supplementary Figure S6). This observation is not
surprising given the abundance of cytosines in gene bodies
and telomeric ends relative to the rest of the P. falciparum
genome (22). Furthermore, the cytosines in these regions
are predominantly in the CHH context, suggesting that a
majority of the modified cytosines in the parasite genome
may be in an asymmetric context, as was revealed by the
BS- and oxBS-seq analysis in Figure 2E.
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S3); this preliminary examination indicated that ∼0.3–0.4%
of the sequenced cytosines were modified in the three biological replicates of the R and S samples from both strains.
The data were further processed using Methylkit (40) to
identify 5hmC (or 5hmC-like) and 5mC loci at the parameters specified above, resulting in an average of 8897 5hmClike loci for the NF54varsporo R stage or 0.20% of all genomic cytosines (Cs; numbering 4512612 in the P. falciparum genome), 9490 5hmC-like loci for the NF54varsporo S
stage or 0.21% of all Cs, 11872 5hmC-like loci for the 3D7G7 R stage or 0.26% of all Cs, and 11640 5hmC-like loci
for the 3D7-G7 S stage or 0.26% of all Cs (Figure 2B; Supplementary Tables S4 and 5)––these values are comparable to those observed in Figure 1C. Moreover, we detected
very low levels of 5mC in the parasite, with a total of 680–
720 unique 5mC loci in the various samples accounting for
0.01–0.02% of genomic cytosines (Supplementary Figure
S4A and Tables S6-7).
We next performed a Pearson Correlation analysis of the
5hmC-like profiles of NF54varsporo R & S and 3D7-G7 R
& S replicates and found to our surprise that the correlation coefficient R ranged from −0.85 to 1 (Figure 2C),
with replicates of the same strain and stage showing variable correlations––for example, the biological replicates of
the NF54varsporo R and 3D7-G7 S stages were positively correlated, whilst those of the NF54varsporo S and 3D7-G7 R
stages were not. This was emphasized by the low overlap in
the exact nucleotide position of the 5hmC-like loci amongst
biological replicates (Figure 2D). Technical replicates for a
single genomic DNA sample further confirmed this observation (Supplementary Figure S5). Because our analysis of
the spike-in DNA controls indicated that both oxidation
and bisulfite conversion efficiencies of the BS- and oxBSseq methods are close to 100% for non-parasite DNA (Supplementary Figure S3), we conclude that this method generates incomplete bisulfite modifications when applied to
the high AT-rich P. falciparum genome (>80% AT content).
We therefore decided to use another reference method to
perform genome-wide 5hmC-like analysis of P. falciparum
blood stage DNA.
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We then identified the genes that are associated with
5hmC-like loci by intersecting the hmeDIP-enriched peaks
with annotated features of the P. falciparum genome (Supplementary Table S9). As shown in Figure 4B, 2539, 2735
and 2507 genes have this cytosine modification in the Ring,
Trophozoite and Schizont stages, respectively, and a majority of these genes carry the modification within the gene
body relative to the 1 kb upstream and downstream regions. However, there are some instances wherein a gene
has 5hmC-like modifications in its gene body as well as
in the 1 kb upstream and/or downstream regions, indicating that the MACS2-derived peak is spread across multiple areas of the same genic region (Figure 4B). We also analyzed the overlap in the 5hmC-like-associated genes between the different growth stages and found that ∼2200

genes, i. e. >80%, are stably marked with 5hmC-like modifications in the Ring, Trophozoite and Schizont stages (Figure 4C). An example of a stably modified region of chromosome 4 is shown in Figure 4D. Nonetheless, there are
some genes that appear to be dynamically marked during
the Ring-Trophozoite-Schizont-Ring transitions (Supplementary Figure S7) and point to potentially specific roles
of the 5hmC-like mark in gene regulation and parasite development.
5hmC-like levels within gene bodies positively correlate with
P. falciparum gene expression
Given that a majority of hmeDIP-enriched peaks were
distributed within genic regions, more specifically within
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Figure 3. hmeDIP-seq performs robustly for the AT-rich Plasmodium falciparum genome. (A) Schematic representation of the hmeDIP-seq methodology
used to measure 5hmC (or 5hmC-like) distribution in P. falciparum asexual stages. Sheared P. falciparum genomic DNA was immunoprecipitated using anti5hmC antibodies and the resulting DNA processed for Next Generation Sequencing (NGS). MACS2 was used for 5hmC-like peak-calling. See Materials
and Methods for additional details. (B) Correlation between hmeDIP-seq biological replicates (calculated for bam alignment files derived from Illumina
sequencing data) for the Ring (R), Trophozoite (Troph or T) and Schizont (Schiz or S) stages of 3D7-G7 was determined using a Pearson correlation
analysis. The colour scale indicates values of the Pearson correlation coefficient R from 0 to 1. Ctrl = Control IP for biological replicate 1. A and B
are technical replicates for the same genomic DNA sample. (C) Correlation of MACS2 fold enrichment (FE) profiles of hmeDIP-seq samples relative to
Input DNA for the Ring (R), Trophozoite (T) and Schizont (S) stages of 3D7-G7 was compared to the IgG control IPs relative to Input DNA. For each
stage, data were normalized across all replicates to generate a single FE profile (described in ‘Materials and Methods’ section). The colour scale indicates
values of the Pearson correlation coefficient R from 0 to 1. Ctrl = Control IP for biological replicate 1. (D) Principal Component Analysis of the different
MACS2-derived FE profiles of part C was performed using the plotPCA function of DeepTools on a multibigwigsummary file. The eigenvalues of the
top two principal components PC1 (54.3% of variance explained) and PC2 (31.3% of variance explained) are shown and meaningful clustering of samples
indicated.
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gene bodies (Figures 4A and B), we asked if gene body
5hmC-like levels correlated with mRNA expression. We
performed RNA-seq-based transcriptomic analysis of total RNA isolated from the parasite cultures that were used
for genomic DNA preparation and extracted reads that
mapped to ∼5670 P. falciparum genes (Supplementary Table S10; fragments per kilobase of transcript per million
reads or FPKM). Next, for each stage and each replicate,
we compared the average expression of genes that were hydroxymethylated in the gene body to unhydroxymethylated
genes and found that hydroxymethylated genes had significantly higher levels of mRNA expression in all stages analysed in this study (Figure 5A; Supplementary Figure S8
and Table S11A). A similar correlation has been observed
in neuronal cells, where 5hmC levels in gene bodies positively correlates with transcriptional activity (10–12). Interestingly, we found that hydroxymethylation in the 1 kb
upstream and 1 kb downstream regions of genes also correlated with higher gene expression (Supplementary Tables
S11B and C), with a stronger effect of 5hmC-like peaks in

the 1 kb downstream regions on gene expression. However,
because a majority of these peaks are contiguous with gene
body peaks, we cannot attribute a regulatory role to them
at this stage.
We next evaluated whether the 2178 genes that maintain gene body hydroxymethylation in the Ring, Trophozoite and Schizont stages (Figure 4C) have higher expression throughout the parasite lifecycle. We measured average transcriptional activity of these genes for each stage
(and each replicate) and compared them to the remaining genes. As shown in the inset in Figure 5B and Supplementary Table S11D, the steady state mRNA levels of the
stably hydroxymethylated genes were significantly higher
than the remaining P. falciparum genes in all three stages.
Gene ontology (GO) analysis revealed that these genes
are enriched for GO terms such as nucleus, myosin complex, cytoskeleton, regulation of RNA metabolic process,
inorganic anion transport, translational initiation, protein
phosphorylation, carbohydrate derivative binding, purine
ribonucleoside triphosphate binding, ion binding, nucleic
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Figure 4. 5hmC-like bases occur predominantly in genic regions of the Plasmodium falciparum genome and are stably maintained during intra-erythrocytic
development. (A) The number of hmeDIP-enriched peaks found in genic (red bars; 1 kb upstream, green bars; gene body and blue bars; 1 kb downstream)
and intergenic (black bars) regions was calculated for the indicated growth stage from the hmeDIP-seq data: Troph = Trophozoite and S = Schizont. (B)
Genes containing 5hmC-like loci either in the gene body or within their 1 kb upstream or downstream flanks were identified for the Ring, Trophozoite
(Troph) and Schizont (Schiz) stages of the 3D7-G7 strain. A Venn diagram was used to represent the overlap in 5hmC-like-associated genes for the different
sub-domains of a genic region. (C) A Venn diagram was used to represent the overlap in 5hmC-like-associated genes for the indicated sub-region across
different P. falciparum growth stages: Troph = Trophozoite and S = Schizont. (D) The hmeDIP-seq and MACS2-derived fold enrichment (FE) pofiles for
a 35 kb region of chromosome 4 (dark blue) are shown for the Ring, Trophozoite (Troph) and Schizont (Schiz) stages. MACS2-derived peaks are shown
underneath the FE profiles. The coverage of bam files for hmeDIP-enriched DNA (red), DNA enriched in the control IP (green), or Input DNA (black)
is shown and was calculated as reads per million over bins of 1000 nt. The GC plot (light blue) represents the G+C content of the P, falciparum genome
normalized across bins of 1000 nt.
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acid binding, hydrolase activity (acting on acid anhydrides),
motor activity, DNA-binding transcription factor activity,
calmodulin binding and actin binding (Figure 5C and Supplementary Table S12). Hence, it appears that housekeeping pathways that are associated with the regulation of gene
expression, cellular signalling and cytoskeletal organization may be fine-tuned via this newly discovered 5hmC-like
modification.
Mass spectrometry analysis posits the presence of a cytosine
DNA modification in P. falciparum genomic DNA that is distinct from 5hmdC and 5mdC
To verify the presence of cytosine modifications in P. falciparum, we surveyed the P. falciparum genome using mass
spectrometry (MS). For this, we digested the genomic
DNA (gDNA) extracted from asexual blood stage parasites in the presence of anti-oxidants and deaminase inhibitors. Collision-induced dissociation (CID) causes the
loss of the 2 -deoxyribose moiety (m/z 116.1) from both
5-hydroxymethyl-2 -deoxycytidine (5hmdC) and 5-methyl-

2 -deoxycytidine (5mdC), leaving a protonated pyrimidine
ring for both bases with m/z ratios of 142.1 and 126.1, respectively, which was monitored using an Agilent 6490 QqQ
mass spectrometer (Supplementary Table S13). In order to
make our detection more robust, we used a second qualifier
transition of 258.1>124.1 and 258.1>109.1, which corresponds to a further loss of a water and ammonia molecule
from the pyrimidine base for 5hmdC and 5mdC, respectively (Figure 6 and Supplementary Figure S9). An analysis of the LC-MS chromatogram shows distinctly the elution of two species at 2.00 min and 3.71 min corresponding to the commercial 5hmdC and 5mdC standards respectively for both of the monitored transitions. These peaks are
also visible in the calf thymus DNA, which was used as a
positive control. Two biological replicates of hydrolysed P.
falciparum gDNA provided a very small signal for 5mdC
(∼0.05% of total dC content), confirming the results of the
biochemical methods that we used (Figures 1 and 2), and
failed to provide a signal for 5hmdC altogether. We, however, noticed the elution of a cryptic peak at 2.75 min and
5.72 min for the transitions that match 5hmdC and 5mdC
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Figure 5. 5hmC-like distribution within gene bodies is positively correlated to mRNA levels. (A) The expression of genes with (green) or without (red)
5hmC-like peaks in the gene body is displayed as a box and whisker plot for one replicate of the Ring (Rep 1), Trophozoite (Troph; Rep 1) and Schizont
(Schiz; Rep 1) stages of the 3D7-G7 strain. For each box and whisker plot, the mean is indicated as a dashed line and the median as a solid line within
the box. Y-axis: FPKM (fragments per kilobase of transcript per million mapped reads) measured using strand-specific RNA-seq. For each comparison,
P-values were calculated using the non-parametric Mann–Whitney U-test. * indicates a P-value < 0.001. Refer to Supplementary Figure S5 and Table
SS5A for the other replicates (B) Left panel: The intersection of 5hmC-like-associated genes (peaks within gene body) identified in the Ring, Trophozoite
(Troph) and Schizont (Schiz) stages of the 3D7-G7 strain are represented using a Venn diagram. Right panel: The table summarizes the expression (Average
RPKM) of 2178 overlapping genes relative to the remaining genes in replicate 1 of the indicated growth stage. The P-value was calculated using the nonparametric Mann–Whitney U-test. Refer to Supplementary Table S5D for the remaining replicates. (C) Gene Ontology (GO) analysis of genes that contain
5hmC-like loci within the gene body in all three stages of the 3D7-G7 strain was performed using https://plasmodborg. Background refers to the number
of genes annotated to the indicated GO term in the entire background set, which in this case is comprised of all annotated P. falciparum genes. MF =
Molecular Function; BP = Biological Process; CC = Cellular Component. Refer to Supplementary Table S6 for additional details.
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respectively in P. falciparum gDNA (Figure 6 and Supplementary Figure S9). Spiking in commercial 5hmdC standard in hydrolysed gDNA showed a concomitant increase
in the signal at 2.00 min and no change at 2.75 min indicating that the digestion matrix did not contribute to a shift
in the retention time and could not account for the cryptic
peak (Supplementary Figure S10). Taken together, the MS
data indicate the presence of a cytosine modification in P.

falciparum genomic DNA – corresponding to the unknown
peak that eluted at ∼2.75 min in Figure 6––that is distinct
from 5hmdC and 5mdC, and which remains to be characterized.
DISCUSSION
In the past 10 years, cytosine hydroxymethylation has
emerged as an integral component of the epigenetic land-
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Figure 6. hm5dC is not detectable in Plasmodium falciparum DNA by mass spectrometry but there is evidence for another type of modified nucleoside.
LC-MS/MS spectra captured using Multiple Reaction Monitoring (MRM) mode are shown for two transitions, (A) 258.1>142.1 and (B) 258.1>124.1, for
two replicates (Rep 1 and Rep 2) of P. falciparum genomic DNA. Calf Thymus DNA and a synthetic standard purchased from Cayman Chemicals served
as positive controls, and showed hm5dC (i.e. 5hmC) elution at 2.00 min at room temperature. ? signifies an unknown peak that elutes at approximately 2.75
min for both transitions. The no DNA ‘Matrix’ control included enzymes, inhibitors and other buffers. Note that the y-axis scales of the various samples
are not linked.
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chracterization of 5hmC-like. Nonetheless, the application
of anti-5hmC antibodies in hmeDIP-seq to study a new cytosine mark and its genome-wide distribution is an important outcome of our study. hmeDIP-seq also overcomes any
concerns that arise from incomplete chemical conversion in
BS- and oxBS-seq (70–72), especially in light of the AT-rich
nature of the P. falciparum genome, which lacks CpG islands and contains Cs primarily in a CHH context (22).
Intriguingly, our biochemical data reveal a low
methylation/hydroxymethylation ratio in malaria parasites, which contrasts to the situation described in a
number of mammalian cell types, where 5mC is detected
at higher levels compared to 5hmC (55–57). For example,
in HEK293 cells, 5mC accounts for 4% of total Cs whilst
5hmC accounts for 0.12% (35); these numbers are even
lower in human pancreatic cells (73) (Supplementary Figure S1B). The exceptions include ESCs and different brain
tissues, where 5hmC has been detected at elevated levels
within gene bodies and has been associated to a role in gene
activation (10–12). In fact, the highest levels of 5hmC have
been observed in brain cells from the frontal cortex of adult
mice, with 5hmC at 0.87% of total Cs accounting for 17.2%
of modified Cs (10) (Supplementary Figure S1B). However,
the molecular basis of the dominance of 5hmC-like marks
over 5mC in P. falciparum is currently unclear. One possibility is that the high oxidative environment within the
infected erythrocyte may enhance the cytosine transition
from methylation to hydroxymethylation or other similar
derivatives such as 5hmC-like and determine their stability.
The genome-wide distribution pattern of 5hmC-like loci
in P. falciparum revealed that this mark is predominantly
genic in nature, with more than >95% of 5hmC-like peaks
mapping to gene bodies. This has been observed in other
cell types of higher eukaryotes where 5hmC was primarily detected in enhancers and transcribed sequences and
was depleted from intergenic regions (9–11,62,64,74,75).
Consequently, 5hmC-like levels in the gene bodies of several P. falciparum genes positively correlated to mRNA
levels, which is in agreement with studies in mouse ESCs
(11). Given that a majority of 5hmC-marked genes maintain the mark during asexual blood development, our data
suggest that this mark may add a layer of epigenetic control that favors higher transcriptional rates by introducing subtle changes in the chromatin, by influencing nucleosome positioning and/or by recruiting RNA polymerase
II to these genes. Nonetheless, genetic validation of the role
of 5hmC-like in P. falciparum gene regulation awaits the
identification of protein(s) involved in writing and reading
this cytosine mark. Our inability to identify an ortholog
to mammalian TET proteins by bioinformatic approaches
is not surprising: for Plasmodium spp., orthologs of conserved pathways, structures or organelles are frequently difficult to identify by sequence homology alone––for example, only a very small fraction of proteins constituting the
nuclear pore complex (NPC) can be identified in P. falciparum using bioinformatics tools (22) although the NPC
can be visualized using several imaging approaches (76).
We cannot exclude that this pathogen has evolved other
pathways for modified cytosine synthesis as has been suggested for plants (77). Alternately, P. falciparum may co-opt
the SOS response-associated peptidase (SRAP) domain-
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scape in higher eukaryotes. Nevertheless, its regulatory role
in model organisms and lower eukaryotes is relatively unexplored, partly due to the very low levels of 5mC and/or
5hmC in these organisms (0.03–0.06%) (65–67). Importantly, cytosine hydroxymethylation or similar derivatives
have never been reported for a eukaryotic pathogen, making our study the first such report. Indeed, our findings
that high levels of cytosine hydroxymethylation (0.2–0.4%)
is correlated to general gene expression in the malaria parasite emphasize, once again, the need to study epigenetic processes in non-model systems to gain insights into organismspecific, novel modes of gene regulation.
Plasmodium falciparum epigenetic regulation governs
pathogenesis in humans (16,17) and therefore, for several
decades, there has been interest in studying the role of DNA
modifications in P. falciparum gene regulation. A number
of reports provided experimental evidence that the parasite
genome does not contain the so-called fifth DNA base 5mC
(23,24,26) and this was further supported by the absence
of DNMT1 and DNMT3 homologues in the malaria parasite (22). One exception was the indirect detection of 5mC
within the genomic locus of the dihydrofolate reductasethymidine synthase (DHFR-TS) gene by restriction mapping (27). In 2013, Ponts et al. reported 5mC in genomic
DNA prepared from an asynchronous P. falciparum blood
stage culture using MS (0.36% to 1.31%) and BS-seq (28).
In the light of our data - we detect very low levels of 5mC
by MS in genomic DNA prepared from parasites grown
in blood free of white blood cells (Supplementary Figure
S9) - the reported values for cytosine methylation by Ponts
et al. could be attributed to several experimental shortcomings. First, their methodology for genomic DNA preparation did not eliminate human white blood cells, which are
present during standard P. falciparum in vitro culture (relevant to their MS observations); second, it is now wellestablished that 5mC and 5hmC are not distinguished by
BS-seq (29); and third, the authors do not provide any information about the reproducibility of their BS-seq experiments. Given that biological and technical replicates of BSand oxBS-seq were poorly correlated in our study, our data
challenge the results of Ponts et al. Moreover, our subsequent MS analyses demonstrate that a new cytosine modification(s) 5hmC-like exists in the parasite genome, which
may be less reactive than 5hmC with the oxidizing agent of
oxBS-seq, potassium perruthenate, and more reactive than
5mC and 5hmC with sodium bisulfite. Overall, we caution
that BS- and oxBS-seq has technical shortcomings that preclude this method to study cytosine modifications in P. falciparum.
Our study also indicates that the new cytosine form,
5hmC-like, is consistently detected by a reference anti5hmC monoclonal antibody in asexual stages of P. falciparum. Because this monoclonal antibody has been widely
used in several model systems to detect 5hmC (9,55,62–
64), and because our biochemical studies are reproducible,
we infer that the anti-5hmC antibody is cross-reacting
with 5hmC-like in parasite genomic DNA. A similar crossreactivity has been observed for RNA modifications such
as N6-methyladenosine and N6,2 -O-dimethyladenosine
(m6Am) (68), and other DNA and RNA modifications (69).
The molecular basis of cross-reactivity awaits the chemical
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tification of a novel predominant type of cytosine modification points to a new epigenetic layer that contributes
to mRNA expression. Our work opens up avenues to explore the pathway that leads to the synthesis of the 5hmClike DNA modification and the reader protein of this mark.
Given that cytidine analogs and DNMT inhibitors block
parasite growth ((28) and our unpublished data), our work
also raises interest to exploit cytosine modifications for new
intervention strategies against malaria parasites.
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Ramı́rez,F., Ryan,D.P., Grüning,B., Bhardwaj,V., Kilpert,F.,
Richter,A.S., Heyne,S., Dündar,F. and Manke,T. (2016) deepTools2:
a next generation web server for deep-sequencing data analysis.
Nucleic Acids Res., 44, W160–W165.
Langmead,B. and Salzberg,S.L. (2012) Fast gapped-read alignment
with Bowtie 2. Nat. Methods, 9, 357–359.
Zhang,Y., Liu,T., Meyer,C.A., Eeckhoute,J., Johnson,D.S.,
Bernstein,B.E., Nusbaum,C., Myers,R.M., Brown,M., Li,W. et al.
(2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9,
R137.
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